S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)

InMed Pharmaceuticals (INM) Insider Trading & Ownership

$0.43
+0.02 (+5.68%)
(As of 03:58 PM ET)

InMed Pharmaceuticals (NASDAQ:INM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.39%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$29,601.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get INM Insider Trade Alerts

Want to know when executives and insiders are buying or selling InMed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

INM Insider Buying and Selling by Quarter


InMed Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/21/2024Andrew HullDirectorBuy37,500$0.39$14,625.00  
2/20/2024Eric A AdamsCEOBuy41,600$0.36$14,976.00  
(Data available from 1/1/2013 forward)












INM Insider Trading Activity - Frequently Asked Questions

Who is on InMed Pharmaceuticals's Insider Roster?

The list of insiders at InMed Pharmaceuticals includes Andrew Hull, Bruce Colwill, Eric A Adams, and Shane Aaron Johnson. Learn more on insiders at INM.

What percentage of InMed Pharmaceuticals stock is owned by insiders?

1.39% of InMed Pharmaceuticals stock is owned by insiders. Learn more on INM's insider holdings.

Which InMed Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased INM shares in the last 24 months: Andrew Hull ($14,625.00), and Eric A Adams ($22,252.00).

How much insider buying is happening at InMed Pharmaceuticals?

Insiders have purchased a total of 87,660 INM shares in the last 24 months for a total of $36,877.00 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:INM) was last updated on 2/26/2024 by MarketBeat.com Staff